Trial Profile
A Safety, Tolerability, and Pharmacokinetic Clinical Trial of AX-024.HCl to Evaluate A) Potential Food Effect and B) Multi-dosing in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2016
Price :
$35
*
At a glance
- Drugs AX 024 (Primary)
- Indications Asthma; Multiple sclerosis
- Focus Adverse reactions
- Sponsors Artax Biopharma
- 08 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Sep 2015 New trial record